<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Much of the morbidity and mortality in <z:e sem="disease" ids="C0002895" disease_type="Disease or Syndrome" abbrv="">sickle cell disease</z:e> (SCD) is caused by tissue <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and infarction resulting from <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Research in this area has been dominated by the hypothesis that <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusion</z:e> in SCD is due primarily to microvascular obstruction by sickle erythrocytes (SS RBC), yet there is no direct evidence that microvascular occlusion is responsible for any of the vasocclusive complications of SCD </plain></SENT>
<SENT sid="2" pm="."><plain>In this paper an alternate hypothesis is proposed: that thrombotic occlusion of larger arteries and veins is an important factor in many of the vasocclusive complications of SCD </plain></SENT>
<SENT sid="3" pm="."><plain>Large-vessel <z:e sem="disease" ids="C0007774" disease_type="Disease or Syndrome" abbrv="">cerebral arterial disease</z:e> (intimal <z:mpath ids='MPATH_134'>hyperplasia</z:mpath> with superimposed <z:mp ids='MP_0005048'>thrombosis</z:mp>) has clearly been established as the most important cause of <z:hpo ids='HP_0001297'>stroke</z:hpo> in SCD, and considerable evidence suggests that pulmonary <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo>/embolism is a major cause of <z:e sem="disease" ids="C0034074" disease_type="Disease or Syndrome" abbrv="">pulmonary infarction</z:e> and <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The involvement of large-vessel <z:mp ids='MP_0005048'>thrombosis</z:mp> in painful crisis, <z:hpo ids='HP_0010885'>aseptic necrosis</z:hpo> of bone, <z:hpo ids='HP_0200023'>priapism</z:hpo>, leg <z:mpath ids='MPATH_579'>ulcers</z:mpath>, <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, and <z:e sem="disease" ids="C0000786" disease_type="Disease or Syndrome" abbrv="">miscarriage</z:e> has not been adequately investigated </plain></SENT>
<SENT sid="5" pm="."><plain>Large-vessel occlusion in SCD is probably a consequence of the abnormal adhesive and procoagulant properties of SS RBC, which produce endothelial damage, secondary intimal proliferation, and <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Techniques currently used to treat large-vessel occlusion in other disorders (antiplatelet and <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> agents, thrombolytic therapy, angioplasty, endarterectomy, and vascular bypass surgery) should be considered in sickle cell subjects with large-vessel occlusion, especially in the cerebral vasculature </plain></SENT>
</text></document>